PM
WGS icon

Prosight Management’s GeneDx Holdings WGS Stock Holding History

Prosight Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.87M Sell
85,500
-437,963
-84% -$24.9M 1.01% 22
2026
Q1 		$33.6M Buy
523,463
+468,463
+852% +$42.7M 5.51% 6
2025
Q4 		$7.15M Buy
+55,000
New +$7.55M 1.48% 22

Other funds holding WGS

CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Prosight Management's WGS Position: Q2 2026 in Review

Prosight Management reduced its GeneDx Holdings (WGS) stake by 84% in Q2 2026, selling an estimated $24.9M and leaving 85,500 shares worth $5.87M. The position accounts for 1.01% of the portfolio, ranked #22.

Prosight Management first reported a position in WGS in Q4 2025 and has held it in 3 quarters since. The position peaked at $33.6M in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Prosight Management held 85,500 shares of GeneDx Holdings worth $5.87M as of Q2 2026.
  • Prosight Management sold 437,963 GeneDx Holdings shares in Q2 2026, an estimated $24.9M.
  • GeneDx Holdings made up 1.01% of Prosight Management's portfolio in Q2 2026, its #22 holding.
  • Prosight Management first reported a position in GeneDx Holdings in Q4 2025 and has held it in 3 quarters since.
  • Prosight Management's GeneDx Holdings position peaked at $33.6M in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Prosight Management's 13F filing for Q2 2026, filed 14 Aug 2026.